The purpose of this study is to learn how the changes of pregnancy can affect how much of an HIV drug (called doravirine) remains in your body. This study will help us understand the right dosage of this medication.
Thank you for your interest, but this study is not currently enrolling.
North Carolina (Statewide)
Angela Kashuba
UNC Eshelman School of Pharmacy-Office of the Dean
Clinical or Medical
Interventional
HIV/AIDS
LGBTQIA+
Pregnancy
Women's Health
20-0052
Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.
Questions?
